Gw Pharmaceuticals Plc Receivables Turnover Ratio (GWPH), from the first quarter 2021 to the first quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gw Pharmaceuticals Plc  (NASDAQ: GWPH)
 

Gw Pharmaceuticals Plc Accounts Receivables Turnover Ratio from the first quarter 2021 to the first quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Gw Pharmaceuticals Plc's ability to collect accounts receivable sequentially worsen to 7.06, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Gw Pharmaceuticals Plc's Accounts Receivable average collection period in the Mar 31 2021 quarter, has increased to 52 days, from 51 days, in the Dec 31 2020 quarter.

If we take a look into Healthcare sector 272 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2054, from overall ranking in the fourth quarter 2020 at 2986.

What is Receivable Turnover Ratio?
What is Gw Pharmaceuticals Plc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GWPH Receivables Turnover Ratio (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Receivable Change 36.55 % 45.59 % 92.32 % 150.23 % 223.15 %
Y / Y Revenue Change 26.39 % 35.89 % 50.66 % 68.38 % 207.37 %
Receivable Turnover Ratio (TTM) 7.06 7.17 7.18 7.58 8.49
GWPH's Total Ranking # 2054 # 2986 # 2985 # 2985 # 2985
Accounts Receivable average collection period days 52 51 51 48 43
Seq. Receivable Change 19.36 % -11.51 % 0.08 % 29.17 % 27.26 %
Seq. Revenue Change 2.86 % 8.15 % 12.99 % 0.55 % 10.6 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 96
Healthcare Sector # 273
Overall Market # 2054

Receivable Turnover Ratio Statistics
High Average Low
14.6 8.5 7.06
(Sep 30 2018)   (Mar 31 2021)





GWPH Company Profile • Back to GWPH Efficiency Comparisons • Compare GWPH Receivables Turnover Ratio to its Competitors

Financial Statements
Gw Pharmaceuticals Plc's Accounts Receivable $ 85 Millions Visit GWPH's Balance sheet
Gw Pharmaceuticals Plc's Sales TTM $ 559 Millions Visit GWPH's Income Statement
Sources of GWPH's Revenues Visit GWPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GWPH's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GWPH's Growth Rates GWPH's Roa GWPH's Inventory Turnover Ratio GWPH's Dividend Comparisons
GWPH's Profitability Ratios GWPH's Roi GWPH's Asset Turnover Ratio GWPH's Dividend Growth
GWPH's Valuation Ratios GWPH's Roe GWPH's Financial Strength Ratios GWPH's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2021 Receivable at quarter ending Mar 31 2021
Chemed Corporation  17.61 $ 2,091.145  Millions$ 118.732  Millions
Mannkind Corporation  17.35 $ 66.345  Millions$ 3.823  Millions
Dbv Technologies S a   17.03 $ 9.497  Millions$ 0.558  Millions
Inhibikase Therapeutics Inc   16.91 $ 1.407  Millions$ 0.083  Millions
Lensar Inc   16.82 $ 27.519  Millions$ 1.636  Millions
Mymetics Corporation  16.64 $ 0.603  Millions$ 0.036  Millions
Neurometrix Inc   15.89 $ 7.361  Millions$ 0.463  Millions
Agenus Inc  15.86 $ 84.761  Millions$ 5.343  Millions
Cormedix Inc   15.81 $ 0.253  Millions$ 0.016  Millions
Skinvisible Inc   15.76 $ 0.156  Millions$ 0.010  Millions
Rafael Holdings Inc  15.55 $ 4.242  Millions$ 0.273  Millions
Myomo Inc   15.44 $ 8.912  Millions$ 0.577  Millions
La Jolla Pharmaceutical Company  15.22 $ 59.965  Millions$ 3.940  Millions
Emmaus Life Sciences Inc   14.98 $ 21.548  Millions$ 1.438  Millions
One World Products Inc   14.97 $ 0.083  Millions$ 0.006  Millions
Ultragenyx Pharmaceutical Inc   14.72 $ 334.116  Millions$ 22.695  Millions
Arrowhead Pharmaceuticals Inc   14.65 $ 89.123  Millions$ 6.085  Millions
Corcept Therapeutics Inc  14.61 $ 340.064  Millions$ 23.270  Millions
Semler Scientific inc   14.55 $ 42.356  Millions$ 2.911  Millions
Cytokinetics Incorporated  14.50 $ 58.551  Millions$ 4.038  Millions
Ibio inc   14.34 $ 3.000  Millions$ 0.209  Millions
Chimerix Inc   14.21 $ 5.566  Millions$ 0.392  Millions
Alpha Pro Tech Ltd   14.04 $ 107.707  Millions$ 7.669  Millions
Protalix Biotherapeutics inc   14.01 $ 52.572  Millions$ 3.752  Millions
Apria inc   13.98 $ 275.274  Millions$ 19.691  Millions
Therapeutic Solutions International Inc   13.71 $ 0.064  Millions$ 0.005  Millions
Ppd Inc   13.70 $ 4,987.392  Millions$ 363.982  Millions
Travere Therapeutics Inc   13.63 $ 197.959  Millions$ 14.523  Millions
Rockwell Medical inc   13.39 $ 61.813  Millions$ 4.616  Millions
Patterson Companies Inc   13.37 $ 5,912.066  Millions$ 442.344  Millions

Date modified: 2026-10-15T05:23:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.